This invention is directed to novel pyranosyl cytosine compounds depicted graphically as structure I. This invention is further directed to a unique methodology for their preparation using solid-phase methodology. These hexopyranosyl cytosine derived natural product analogs share their parent compounds broad-spectrum antimicrobial and anti-fungal profile and represent a vast, novel compound class of 50S rRNA directed inhibitors of protein translation.
1
这项发明涉及以图示结构I形式表示的新型
吡喃基
胞嘧啶化合物。该发明进一步涉及一种独特的固相方法用于它们的制备。这些以己糖基
胞嘧啶为基础的
天然产物类似物与它们的母体化合物共享广谱抗微
生物和抗真菌特性,并代表了一类广泛的、新型的50S rRNA定向蛋白翻译
抑制剂化合物。